<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="id">2061</item><item key="factors"><item><item key="GSM1358075"><item key="HOST">A2D mice</item><item key="TREATMENT">Ara-C treatment for 2 days</item><item key="CELL TYPE">residual cells</item></item></item><item><item key="GSM1358075"><item key="HOST">A2D mice</item><item key="TREATMENT">Ara-C treatment for 2 days</item><item key="CELL TYPE">residual cells</item></item></item><item><item key="GSM1358075"><item key="HOST">A2D mice</item><item key="TREATMENT">Ara-C treatment for 2 days</item><item key="CELL TYPE">residual cells</item></item></item><item><item key="GSM1358072"><item key="HOST">A0D mice</item><item key="TREATMENT">no Ara-C treatment</item><item key="CELL TYPE">engrafted NALM-6-GFP+ cells</item></item></item><item><item key="GSM1358072"><item key="HOST">A0D mice</item><item key="TREATMENT">no Ara-C treatment</item><item key="CELL TYPE">engrafted NALM-6-GFP+ cells</item></item></item><item><item key="GSM1358072"><item key="HOST">A0D mice</item><item key="TREATMENT">no Ara-C treatment</item><item key="CELL TYPE">engrafted NALM-6-GFP+ cells</item></item></item></item><item key="pop_total">0</item><item key="platform">4</item><item key="summary_wrapped">Residence of cancer-propagating cells (CPCs) within preferential microenvironmental niches has a major part in evading therapy. However,...</item><item key="geo_gse_id">E-GEOD-56273</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">3</item><item key="sample_count">6</item><item key="tags"><item>acute lymphoblastic leukemia</item><item>bone</item><item>bone marrow</item><item>cancer</item><item>cell</item><item>leukemia</item><item>line</item><item>lymphoblastic leukemia</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">leukemia-propagating-cells-rebuild-an-evolving-nic</item><item key="geo_id_plat">E-GEOD-56273_A-AFFY-44</item><item key="name">leukemia propagating cells rebuild an evolving niche in response to therapy</item><item key="created">Jul.11, 2014</item><item key="summary">Residence of cancer-propagating cells (CPCs) within preferential microenvironmental niches has a major part in evading therapy. However, the nature of niches involved and the mechanisms protecting CPCs remain largely unknown. We addressed these issues in mouse transplantation models of acute lymphoblastic leukemia (ALL). When the engrafted leukemic cells substantially damaged adjacent vascular structures and endosteal linings in the bone marrow (BM), after chemotherapy small foci of CPCs were retained, surrounded by sheaths of supporting cells that comprise a novel niche. We investigated patients&#8217; BM biopsies and found evidence of a similar process in patients receiving induction-therapy. The efficacy of chemotherapy was enhanced by interfering with the niche formation or niche-CPC interaction. We therefore identified a therapy-induced niche that protects CPCs. We used microarrays to compare the  gene expression profile of ALL cell line (Nalm-6) from model (A0D) mice and rediduel cells from Ara-C treatment for 2 days (A2D) mice. Engrafted NALM-6-GFP+ cells from A0D mice and residual cells from A2D mice were flow sorted. Total RNA was isolated using RNeasy micro kit (Qiagen). Biotinylated cRNA was hybridized using HGU133Plus 2.0 GeneChip arrays (Affymetrix).</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-56273</item><item key="species">human</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-56273/samples/</item></data></biogps>
